Browse studies

Find your next paid study

1 recruiting study matching your filters

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

To collect information about treatment outcomes in pediatric and adolescent patients with relapsed/refractory germ cells tumors who receive GemDMC with an ASCT.

Prospective Observational StudyGemcitabineDocetaxel+5 more

Estimated

~$10 – $750

M.D. Anderson Cancer CenterNCT07662018